DNA – Ginkgo Bioworks Holdings, Inc.
DNA — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
18.27
Margin Of Safety %
Put/Call OI Ratio
0.41
EPS Next Q Diff
0.1
EPS Last/This Y
1.25
EPS This/Next Y
0.53
Price
5.92
Target Price
8.5
Analyst Recom
3.67
Performance Q
-33.45
Upside
-2,207.3%
Beta
1.54
Ticker: DNA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | DNA | 6.75 | 0.20 | 2.43 | 15690 |
| 2026-03-02 | DNA | 7.05 | 0.28 | 1.09 | 16898 |
| 2026-03-03 | DNA | 6.71 | 0.29 | 3.35 | 17172 |
| 2026-03-04 | DNA | 6.7 | 0.32 | 0.03 | 17684 |
| 2026-03-05 | DNA | 6.84 | 0.32 | 0.80 | 17635 |
| 2026-03-06 | DNA | 6.51 | 0.32 | 0.18 | 17666 |
| 2026-03-09 | DNA | 6.6 | 0.32 | 0.58 | 17806 |
| 2026-03-10 | DNA | 6.35 | 0.32 | 0.41 | 17835 |
| 2026-03-11 | DNA | 6.85 | 0.32 | 0.75 | 17890 |
| 2026-03-12 | DNA | 6.4 | 0.32 | 0.35 | 17929 |
| 2026-03-13 | DNA | 6.4 | 0.32 | 0.37 | 17929 |
| 2026-03-17 | DNA | 6.81 | 0.30 | 1.07 | 18019 |
| 2026-03-18 | DNA | 6.49 | 0.30 | 0.06 | 17987 |
| 2026-03-19 | DNA | 6.93 | 0.29 | 0.61 | 18314 |
| 2026-03-20 | DNA | 6.73 | 0.29 | 1.70 | 18313 |
| 2026-03-23 | DNA | 7 | 0.40 | 0.12 | 8080 |
| 2026-03-24 | DNA | 7.18 | 0.40 | 0.03 | 8238 |
| 2026-03-25 | DNA | 7.4 | 0.38 | 0.13 | 8569 |
| 2026-03-26 | DNA | 6.41 | 0.37 | 6.72 | 8673 |
| 2026-03-27 | DNA | 5.93 | 0.41 | 1.63 | 8920 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | DNA | 6.75 | 8.5 | - | -5.64 |
| 2026-03-02 | DNA | 7.07 | - | - | -3.69 |
| 2026-03-03 | DNA | 6.70 | - | - | -3.69 |
| 2026-03-04 | DNA | 6.70 | - | - | -3.69 |
| 2026-03-05 | DNA | 6.85 | - | - | -3.69 |
| 2026-03-06 | DNA | 6.51 | - | - | -3.69 |
| 2026-03-09 | DNA | 6.59 | - | - | -3.84 |
| 2026-03-10 | DNA | 6.34 | - | - | -3.84 |
| 2026-03-11 | DNA | 6.84 | - | - | -3.84 |
| 2026-03-12 | DNA | 6.39 | - | - | -3.84 |
| 2026-03-13 | DNA | 6.81 | - | - | -3.84 |
| 2026-03-17 | DNA | 6.83 | - | - | -4.39 |
| 2026-03-18 | DNA | 6.50 | - | - | -4.39 |
| 2026-03-19 | DNA | 6.92 | - | - | -4.39 |
| 2026-03-20 | DNA | 6.73 | - | - | -4.39 |
| 2026-03-23 | DNA | 6.99 | - | - | -4.39 |
| 2026-03-24 | DNA | 7.17 | - | - | -4.39 |
| 2026-03-25 | DNA | 7.40 | - | - | -4.39 |
| 2026-03-26 | DNA | 6.41 | - | - | -4.39 |
| 2026-03-27 | DNA | 5.92 | - | - | -4.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | DNA | -0.18 | 5.06 | 17.05 |
| 2026-03-02 | DNA | -0.18 | 5.58 | 17.05 |
| 2026-03-03 | DNA | -0.19 | 5.58 | 17.05 |
| 2026-03-04 | DNA | -0.19 | 5.58 | 17.05 |
| 2026-03-05 | DNA | -0.18 | 5.58 | 17.05 |
| 2026-03-06 | DNA | -0.18 | 5.58 | 16.57 |
| 2026-03-09 | DNA | -0.19 | 5.29 | 16.57 |
| 2026-03-10 | DNA | -0.19 | 5.29 | 16.57 |
| 2026-03-11 | DNA | -0.06 | 5.29 | 17.08 |
| 2026-03-12 | DNA | -0.06 | 5.29 | 17.08 |
| 2026-03-13 | DNA | -0.06 | 5.29 | 17.08 |
| 2026-03-17 | DNA | -0.06 | 5.62 | 17.08 |
| 2026-03-18 | DNA | -0.06 | 5.62 | 17.08 |
| 2026-03-19 | DNA | -0.06 | 5.62 | 17.08 |
| 2026-03-20 | DNA | -0.06 | 5.62 | 17.08 |
| 2026-03-23 | DNA | -0.06 | 5.62 | 17.08 |
| 2026-03-24 | DNA | -0.06 | 5.62 | 17.08 |
| 2026-03-25 | DNA | -0.06 | 5.62 | 18.27 |
| 2026-03-26 | DNA | -0.06 | 5.62 | 18.27 |
| 2026-03-27 | DNA | -0.06 | 5.62 | 18.27 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.42
Avg. EPS Est. Current Quarter
-1.34
Avg. EPS Est. Next Quarter
-1.32
Insider Transactions
-0.06
Institutional Transactions
5.62
Beta
1.54
Average Sales Estimate Current Quarter
42
Average Sales Estimate Next Quarter
40
Fair Value
Quality Score
29
Growth Score
23
Sentiment Score
15
Actual DrawDown %
99.1
Max Drawdown 5-Year %
Target Price
8.5
P/E
Forward P/E
PEG
P/S
2.14
P/B
0.64
P/Free Cash Flow
EPS
-5.68
Average EPS Est. Cur. Y
-4.39
EPS Next Y. (Est.)
-3.86
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-183.81
Relative Volume
1.46
Return on Equity vs Sector %
-88.8
Return on Equity vs Industry %
-72.6
EPS 1 7Days Diff
-0.8
EPS 1 30Days Diff
-0.47
EBIT Estimation
◆
DNA
Healthcare
$5.93
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
37
Range 1M
4.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
21.5%
EPS NY
12.8%
52W%
7.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+43.3% upside
Upside
+43.3%
Quality
29
Ginkgo Bioworks Holdings, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 485
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
DNA
Latest News
—
Caricamento notizie per DNA…
stock quote shares DNA – Ginkgo Bioworks Holdings, Inc. Stock Price stock today
news today DNA – Ginkgo Bioworks Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DNA – Ginkgo Bioworks Holdings, Inc. yahoo finance google finance
stock history DNA – Ginkgo Bioworks Holdings, Inc. invest stock market
stock prices DNA premarket after hours
ticker DNA fair value insiders trading